litlas
Log inCreate account

David Sulzer

Active 1990–2025

168
Papers
37,468
Citations
103
h-index
165
i10-index

Citations

Citations per year for David Sulzer1951: 1 citations1983: 1 citations1990: 5 citations1991: 1 citations1992: 3 citations1993: 5 citations1994: 7 citations1995: 15 citations1996: 14 citations1997: 30 citations1998: 47 citations1999: 53 citations2000: 120 citations2001: 105 citations2002: 166 citations2003: 272 citations2004: 335 citations2005: 269 citations2006: 351 citations2007: 330 citations2008: 434 citations2009: 419 citations2010: 418 citations2011: 425 citations2012: 394 citations2013: 395 citations2014: 448 citations2015: 410 citations2016: 451 citations2017: 390 citations2018: 515 citations2019: 1,308 citations2020: 1,481 citations2021: 1,548 citations2022: 1,256 citations2023: 969 citations2024: 1,406 citations2025: 652 citations2026: 12 citations1952–1982: no citations, so these years are not shown1984–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,997 citing papers, 32% of this breakdownChina: 1,264 citing papers, 8.1% of this breakdownUnited Kingdom: 992 citing papers, 6.3% of this breakdownGermany: 919 citing papers, 5.9% of this breakdownItaly: 775 citing papers, 5% of this breakdownCanada: 563 citing papers, 3.6% of this breakdownFrance: 513 citing papers, 3.3% of this breakdownJapan: 494 citing papers, 3.2% of this breakdownSpain: 418 citing papers, 2.7% of this breakdownAustralia: 334 citing papers, 2.1% of this breakdownSweden: 323 citing papers, 2.1% of this breakdownIndia: 295 citing papers, 1.9% of this breakdown
0%32%Other 23.8%

Institutions

Fields

  • Medicine47.6%
  • Neuroscience27.2%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Psychology0.9%
  • Immunology and Microbiology0.8%
  • Engineering0.7%
  • Other3%

Topics

  • Parkinson's Disease Mechanisms and Treatments11.6%
  • Neuroscience and Neuropharmacology Research5.6%
  • Autophagy in Disease and Therapy4.6%
  • Neurotransmitter Receptor Influence on Behavior3.8%
  • Alzheimer's disease research and treatments3.7%
  • Neurological disorders and treatments3.6%
  • Other67.1%

Coauthors

All papers

Open in search
  1. T cells from patients with Parkinson’s disease recognize α-synuclein peptides

    Authors: David Sulzer, Roy N. Alcalay, Francesca Garretti, Lucien Côté, Ellen Kanter, Julian Agin‐Liebes, Christopher Liong, Curtis McMurtrey, William H. Hildebrand, Xiaobo Mao, Valina L. Dawson, Ted M. Dawson, Carla Oseroff, John Pham, John Sidney, Myles Dillon, Chelsea Carpenter, Daniela Weiskopf, Elizabeth J. Phillips, S. Mallal, Bjoern Peters, April Frazier, Cecilia S. Lindestam Arlehamn, Alessandro Sette - Nature 2017 cited by 901

  2. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

    Authors: Ana María Cuervo, Leonidas Stefanis, Ross A. Fredenburg, Peter T. Lansbury, David Sulzer - Science 2004 cited by 2,007

  3. Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits

    Authors: Guomei Tang, Kathryn Gudsnuk, Sheng‐Han Kuo, Marisa L. Cotrina, Gorazd Rosoklija, Alexander A. Sosunov, Mark S. Sonders, Ellen Kanter, Candace Castagna, Ai Yamamoto, Zhenyu Yue, Ottavio Arancio, Bradley S. Peterson, Frances A. Champagne, Andrew J. Dwork, James E. Goldman, David Sulzer - Neuron 2014 cited by 1,158

  4. Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome

    Authors: Mathieu Bourdenx, Adrián Martín‐Segura, Aurora Scrivo, José Antonio Rodríguez‐Navarro, Susmita Kaushik, Inmaculada Tasset, Antonio Díaz, Nadia Storm, Qisheng Xin, Yves R. Juste, Erica Stevenson, Enrique Luengo, Cristina C. Clement, Se Joon Choi, Nevan J. Krogan, Eugene V. Mosharov, Laura Santambrogio, Fiona Grueninger, Ludovic Collin, Danielle L. Swaney, David Sulzer, Evripidis Gavathiotis, Ana María Cuervo - Cell 2021 cited by 330

  5. α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

    Authors: Cecilia S. Lindestam Arlehamn, Rekha Dhanwani, John Pham, Rebecca Kuan, April Frazier, Juliana Rezende Dutra, Elizabeth J. Phillips, S. Mallal, Mario Roederer, Karen Marder, Amy W. Amara, David G. Standaert, Jennifer G. Goldman, Irene Litvan, Bjoern Peters, David Sulzer, Alessandro Sette - Nature Communications 2020 cited by 393

  6. Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory

    Authors: Kimberly A. Kempadoo, Eugene V. Mosharov, Se Joon Choi, David Sulzer, Eric R. Kandel - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 669

  7. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

    Authors: Fabio A. Zucca, Juan Segura‐Aguilar, Emanuele Ferrari, Patricia Muñoz, Irmgard Paris, David Sulzer, Tadeusz Sarna, Luigi Casella, Luigi Zecca - Progress in Neurobiology 2015 cited by 665

  8. Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity

    Authors: Nagendran Ramalingam, Shan‐Xue Jin, Tim E. Moors, Luis Fonseca‐Ornelas, Kazuma Shimanaka, Lei Shi, Hugh P. Cam, Aurelia Hays Watson, Lisa Brontesi, Lai Ding, Dinc Yasat Hacibaloglu, Haiyang Jiang, Se Joon Choi, Ellen Kanter, Lei Liu, Tim Bartels, Silke Nuber, David Sulzer, Eugene V. Mosharov, Weisheng V. Chen, Shaomin Li, Dennis J. Selkoe, Ulf Dettmer - npj Parkinson s Disease 2023 cited by 147

  9. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease

    Authors: Marta Martínez‐Vicente, Zsolt Tallóczy, Esther Wong, Guomei Tang, Hiroshi Koga, Susmita Kaushik, Rosa de Vries, Esperanza Arias, Spike Harris, David Sulzer, Ana María Cuervo - Nature Neuroscience 2010 cited by 858

  10. The physiological role of α‐synuclein and its relationship to Parkinson’s Disease

    Authors: David Sulzer, Robert H. Edwards - Journal of Neurochemistry 2019 cited by 318

  11. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

    Authors: Asa Abeliovich, Yvonne Schmitz, Isabel Fariñas, DL Choi-Lundberg, Wei-Hsien Ho, Pablo E. Castillo, Natasha Shinsky, José Manuel García‐Verdugo, Mark Armanini, Anne Ryan, Mary Hynes, Heidi Phillips, David Sulzer, Arnon Rosenthal - Neuron 2000 cited by 1,689

  12. Interplay of LRRK2 with chaperone-mediated autophagy

    Authors: Samantha J. Orenstein, Sheng‐Han Kuo, Inmaculada Tasset, Esperanza Arias, Hiroshi Koga, Irene Fernández‐Carasa, Etty Cortés, Lawrence S. Honig, William T. Dauer, Antonella Consiglio, Ángel Raya, David Sulzer, Ana María Cuervo - Nature Neuroscience 2013 cited by 580

  13. Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy

    Authors: Sheng‐Han Kuo, Inmaculada Tasset, Melody M. Cheng, Antonio Díaz, Ming‐Kai Pan, Ori J. Lieberman, Samantha J. Hutten, Roy N. Alcalay, Sangjun Kim, Pilar Ximénez‐Embún, Li Fan, Donghoon Kim, Han Seok Ko, Talene A. Yacoubian, Ellen Kanter, Ling Liu, Guomei Tang, Javier Muñoz, S. Pablo Sardi, Aiqun Li, Li Gan, Ana María Cuervo, David Sulzer - Science Advances 2022 cited by 147

  14. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

    Authors: Carolina Cebrián, Fabio A. Zucca, Pierluigi Mauri, Julius A. Steinbeck, Lorenz Studer, Clemens R. Scherzer, Ellen Kanter, Sadna Budhu, Jonathan Mandelbaum, Jean Paul Vonsattel, Luigi Zecca, John D. Loike, David Sulzer - Nature Communications 2014 cited by 338

  15. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain

    Authors: Clifford Cassidy, Fabio A. Zucca, Ragy R. Girgis, Seth C. Baker, Jodi J. Weinstein, Madeleine Sharp, Chiara Bellei, Alice Valmadre, Nora Vanegas, Lawrence S. Kegeles, Gary Brucato, Un Jung Kang, David Sulzer, Luigi Zecca, Anissa Abi‐Dargham, Guillermo Horga - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 241

  16. Striatal dopamine neurotransmission: Regulation of release and uptake

    Authors: David Sulzer, Stephanie J. Cragg, Margaret E. Rice - Basal Ganglia 2016 cited by 411

  17. Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases

    Authors: Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, Andrea Capucciati, Chiara Bacchella, Fabio A. Zucca, Eugene V. Mosharov, David Sulzer, Luigi Zecca, Luigi Casella - Angewandte Chemie International Edition 2018 cited by 266

  18. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

    Authors: David Sulzer, Clifford Cassidy, Guillermo Horga, Un Jung Kang, Stanley Fahn, Luigi Casella, Gianni Pezzoli, Jason Langley, Xiaoping Hu, Fabio A. Zucca, Ioannis U. Isaias, Luigi Zecca - npj Parkinson s Disease 2018 cited by 273

  19. Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations

    Authors: Hongyu Li, Ahrom Ham, C. Thong, Sheng‐Han Kuo, Ellen Kanter, Donghoon Kim, Han Seok Ko, Yi Quan, S. Pablo Sardi, Aiqun Li, Ottavio Arancio, Un Jung Kang, David Sulzer, Guomei Tang - Autophagy 2018 cited by 242

  20. Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

    Authors: Marta Martínez‐Vicente, Zsolt Tallóczy, Susmita Kaushik, Ashish C. Massey, Joseph R. Mazzulli, Eugene V. Mosharov, Roberto Hodara, Ross A. Fredenburg, Du-Chu Wu, Antonia Follenzi, William T. Dauer, Serge Przedborski, Harry Ischiropoulos, Peter T. Lansbury, David Sulzer, Ana María Cuervo - Journal of Clinical Investigation 2008 cited by 625

  21. Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons

    Authors: Eugene V. Mosharov, Kristin E. Larsen, Ellen Kanter, Kester A. Phillips, Krystal Wilson, Yvonne Schmitz, David E. Krantz, Kazuto Kobayashi, Robert H. Edwards, David Sulzer - Neuron 2009 cited by 541

  22. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles

    Authors: David Sulzer, Johanna Bogulavsky, Kristin E. Larsen, Gerald Behr, Erdem Karatekin, Mark H. Kleinman, Nicholas J. Turro, David E. Krantz, Robert H. Edwards, Lloyd A. Greene, Luigi Zecca - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 463

  23. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

    Authors: Wei Zhang, Kester A. Phillips, Albert R. Wielgus, Jie Liu, Alberto Albertini, Fabio A. Zucca, Rudolph Faust, Steven Y. Qian, David S. Miller, Colin F. Chignell, Belinda Wilson, Vernice Jackson‐Lewis, Serge Przedborski, Danielle Joset, John D. Loike, Jau‐Shyong Hong, David Sulzer, Luigi Zecca - Neurotoxicity Research 2009 cited by 257

  24. Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

    Authors: Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael G. Schlossmacher, Poul Henning Jensen, Julia M. Schulze‐Hentrich, Olaf Rieß, Warren D. Hirst, Omar M. A. El‐Agnaf, Brit Mollenhauer, Peter T. Lansbury, Tiago F. Outeiro - npj Parkinson s Disease 2021 cited by 178